Notes Payable (Details Narrative) - Bridge Loan Note [Member] - USD ($) |
Mar. 31, 2022 |
Dec. 31, 2021 |
Nov. 11, 2020 |
---|---|---|---|
MyMD Pharmaceuticals (Florida), Inc [Member] | |||
Short-Term Debt [Line Items] | |||
Advances to Affiliate | $ 3,000,000 | $ 3,000,000 | |
Interest Receivable | 26,137 | ||
Notes Receivable, Related Parties | $ 3,026,137 | $ 3,026,137 | |
Merger Agreement [Member] | |||
Short-Term Debt [Line Items] | |||
Maximum principal amount | $ 3,000,000 | ||
Interest rate | 5.00% | ||
Merger Agreement [Member] | Event of Default [Member] | |||
Short-Term Debt [Line Items] | |||
Interest rate | 8.00% |
X | ||||||||||
- Definition Long-Term advances receivable from a party that is affiliated with the reporting entity by means of direct or indirect ownership. This does not include advances to clients. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Face (par) amount of debt instrument at time of issuance. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Contractual interest rate for funds borrowed, under the debt agreement. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Carrying amount as of the balance sheet date of interest earned but not received. Also called accrued interest or accrued interest receivable. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
X | ||||||||||
- Definition For an unclassified balance sheet, amounts due from parties associated with the reporting entity as evidenced by a written promise to pay. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|